Table 1.
Clinical trials registered on ClinicalTrials.gov (as accessed on July 2023) focusing on the impact of the ketogenic diet in treating epilepsy and other neurological conditions, and including the gut microbiome
| Neurological condition | Title | N | Age | Status | Intervention | Location | NCT Number | |
| Epilepsy | Epigenetics and Gut Microbiota in Children With Epilepsy (EpiMICRO) | 60 | 2-17 y | Recruiting | Ketogenic Diet. | Norway | NCT04063007 | |
| Epilepsy | Ketogenic Diet Program for Epilepsy | 30 | 6 m-18 y | Completed | Ketogenic Diet. | United States | NCT02497105 | |
| Epilepsy (DRE) | Role of the Gut Microbiota in Pediatric Epilepsy (EPBiome) | 45 | 2-18 y | Recruiting | Ketogenic Diet. Dietary Supplement: inulin | Canada | NCT04705298 | |
| Autism Spectrum Disorder | Ketogenic Diet Therapy for Autism Spectrum Disorder | 119 | 2-21 y | Completed | Ketogenic Diet. | United States | NCT02477904 | |
| Parkinson’s Disease | Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome (KIM) | 50 | 45-85 y | Not yet recruiting | Mediterranean-Ketogenic Diet. Dietary Supplement: medium-chain triglyceride oil | Canada | NCT05469997 |
DRE: Drug-resistant epilepsy.